A mortality prediction model in diabetic ketoacidosis

被引:50
作者
Efstathiou, SP [1 ]
Tsiakou, AG [1 ]
Tsioulos, DI [1 ]
Zacharos, ID [1 ]
Mitromaras, AG [1 ]
Mastorantonakis, SE [1 ]
Panagiotou, TN [1 ]
Mountokalakis, TD [1 ]
机构
[1] Univ Athens, Sch Med, Sotiria Gen Hosp, Dept Internal Med 3, GR-11527 Athens, Greece
关键词
D O I
10.1046/j.1365-2265.2002.01636.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIM To assess the value of clinical and laboratory parameters in predicting mortality in patients presenting with diabetic ketoacidosis (DKA). METHODS The records of all DKA admissions within 10 years were reviewed. Eighteen variables were evaluated at initial presentation and 20 variables at 4, 12 and 24 h from admission. A scoring system derived from these variables was compared to the APACHE III scoring system. RESULTS Among 154 patients (52 males, mean age 58 +/- 12 years), 20 (13%) died in hospital. Multivariate analysis yielded six variables as significant independent predictors ( P < 0.05) of mortality: severe coexisting diseases (SCD) and pH < 7.0, at presentation; units of regular insulin required in the first 12 h > 50 and serum glucose > 16.7 mmo/l, after 12 h; depressed mental state and fever, after 24 h. An integer-based scoring system was derived, as follows: number of points = 6 (SCD at presentation) + 4 (pH < 7.0 at presentation) + 4 (regular insulin required > 50 IU after 12 h) + 4 (serum glucose > 16.7 mmo/l after 12 h) + 4 (depressed mental state after 24 h) + 3 (fever after 24 h). Patients with 0-14 points had 0.86% risk of death, whereas for those with 19-25 points the risk was 93.3%. Median APACHE III scores differed significantly ( P < 0.001) among groups of patients stratified according to the above scoring system. CONCLUSIONS Risk stratification of patients with diabetic ketoacidosis is possible from simple clinical and laboratory variables available during the first day of hospitalization.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 1977, Statistical Methods in Medical Research
[2]   Hepatorenal syndrome in cirrhosis:: Pathogenesis and treatment [J].
Arroyo, V ;
Guevara, M ;
Ginès, P .
GASTROENTEROLOGY, 2002, 122 (06) :1658-1676
[3]   PERSISTING MORTALITY IN DIABETIC-KETOACIDOSIS [J].
BASU, A ;
CLOSE, CF ;
JENKINS, D ;
KRENTZ, AJ ;
NATTRASS, M ;
WRIGHT, AD .
DIABETIC MEDICINE, 1993, 10 (03) :282-284
[4]   Diabetic ketoacidosis - Why early detection and aggressive treatment are crucial [J].
Bell, DSH ;
Alele, J .
POSTGRADUATE MEDICINE, 1997, 101 (04) :193-&
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]   THE EPIDEMIOLOGY OF DIABETIC ACIDOSIS - A POPULATION-BASED STUDY [J].
FAICH, GA ;
FISHBEIN, HA ;
ELLIS, SE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 117 (05) :551-558
[8]   DIABETIC-KETOACIDOSIS - OUTCOME IN A COMMUNITY-HOSPITAL [J].
GOUIN, PE ;
GOSSAIN, VV ;
ROVNER, DR .
SOUTHERN MEDICAL JOURNAL, 1985, 78 (08) :941-943
[9]   DEATHS ASSOCIATED WITH DIABETIC-KETOACIDOSIS AND HYPEROSMOLAR COMA, 1973-1988 [J].
HAMBLIN, PS ;
TOPLISS, DJ ;
CHOSICH, N ;
LORDING, DW ;
STOCKIGT, JR .
MEDICAL JOURNAL OF AUSTRALIA, 1989, 151 (08) :439-&
[10]  
Hamblin PS, 1989, MED J AUSTRALIA, V151, P441